|Articles|December 16, 2013

BioPharm International

  • BioPharm International-12-16-2013
  • Volume 2013 eBook
  • Issue 1

Leveraging Development Strengths Drives Therapies to Market

NPS Pharmaceuticals uses its expertise in development, regulatory compliance, and commercialization to bring to market products with orphan drug status.

 

Established biopharmaceutical company NPS Pharmaceuticals uses its expertise in development, regulatory compliance, and commercialization to bring to market products with orphan drug status.

Read this article from BioPharm International’s 2013 Innovation Updates and Strategies eBook.

View other articles in the 2013 Innovation Updates and Strategies eBook.

 

 

 

 

Articles in this issue

about 12 years ago

Creating Better Medicines through Better Conjugation

about 12 years ago

Recovering Patent Life with Patent Term Extension

about 12 years ago

Strategic Outsourcing in Clinical Development

about 12 years ago

Driving Innovation in Biopharmaceuticals

about 12 years ago

Crowdfunding Biopharmaceutical Innovation

about 12 years ago

Restructuring for Biopharmaceutical Success

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content